Predictors of Long-term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of Long-term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab

Published:2019-06 Issue:6 Volume:68 Page:841-846
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

D’Arcangelo Giulia,Oliva Salvatore,Dilillo Anna,Viola Franca,Civitelli Fortunata,Isoldi Sara,Cucchiara Salvatore,Aloi Marina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference27 articles.

1. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-totarget;Peyrin-Biroulet;Am J Gastroenterol,2015

2. Update on therapeutic drug monitoring in Crohn's disease;Heron;Gastroenterol Clin North Am,2017

3. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions;Turner;Inflamm Bowel Dis,2012

4. Which PCDAI version best reflects intestinal inflammation in pediatric Crohn disease?;Turner;J Pediatr Gastroenterol Nutr,2017

5. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents;Levine,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Operating Properties of Disease Activity Indices in Pediatric Inflammatory Bowel Disease: A Systematic Review;Inflammatory Bowel Diseases;2024-03-28

2. Precise infliximab exposure and pharmacodynamic control to achieve deep remission in paediatric Crohn’s disease (REMODEL-CD): study protocol for a multicentre, open-label, pragmatic clinical trial in the USA;BMJ Open;2024-03

3. Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel Disease;Current Gastroenterology Reports;2023-09-11

4. Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2022-11-22

5. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy;World Journal of Gastroenterology;2022-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3